14 results
10-Q
2020 Q3
ONCR
Oncorus, Inc.
12 Nov 20
Quarterly report
8:01am
is administered;
liability for harm caused to patients or subjects;
reputational harm;
the product becoming less competitive;
warning, untitled … to resolve allegations of non-compliance, contractual damages, reputational harm, diminished profits and future earnings, and the curtailment or restructuring
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
of operations, the exclusion from participation in federal and state healthcare programs, disgorgement, contractual damages, reputational harm … ;
changes to the way the product candidate is administered;
liability for harm caused to patients or subjects;
reputational harm;
the product becoming
424B4
ONCR
Oncorus, Inc.
2 Oct 20
Prospectus supplement with pricing info
12:00am
the product candidate is administered;
liability for harm caused to patients or subjects;
reputational harm;
the product becoming less competitive … subject to corporate integrity agreements or similar agreement to resolve allegations of non-compliance, contractual damages, reputational harm
DRS/A
f23ui kts
20 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
o2hdl eihpvroip7
26 Aug 20
Draft registration statement (amended)
12:00am
S-1
53t acm71
11 Sep 20
IPO registration
4:49pm
DRS
gcbrngk4l 8tv6i
31 Oct 19
Draft registration statement
12:00am
424B4
knab4px0suf3
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS/A
iy95orba
29 Jul 20
Draft registration statement (amended)
12:00am
DRS
lqsc122e v6gda7a8c
28 Jan 21
Draft registration statement
12:00am
- Prev
- 1
- Next